Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pan-Ppar Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats Publisher



Khazaei M1 ; Salehi E1 ; Rashidi B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Hezar Jarib Ave., Iran
  2. 2. Department of Anatomy, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Peptides Published:2012


Abstract

Introduction. The aim of this study was to investigate the effect of bezafibrate as a pan-PPAR agonist on angiogenesis and serum nitrite, the main metabolite of nitric oxide (NO), vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) concentrations in hindlimb ischemia model of normal and type I diabetic rats. Methods. 28 male Wistar rats were divided into control and diabetic groups. Then, all rats underwent unilateral hindlimb ischemia. After recovery, they were randomly assigned to one of the following experimental groups: (1) control; (2) control+bezafibrate (400mg/kg/day); (3) diabetic; (4) diabetic+beztafibrate. After three weeks, blood samples were taken and capillary density was evaluated in the gasterocnemius muscle of ischemic limb. Results. Bezafibrate increased capillary density and capillary/fiber ratio in ischemic leg of diabetic and control rats (P < 0.05). Serum VEGF and VEGFR-2 concentrations did not alter after bezafibrate administration, however, serum nitrite concentration was significantly higher in bezafibrate-treated groups than non-treated groups (P < 0.05). Discussion. It seems that bezafibrate, as a pan PPAR agonist, restores angiogenesis in hindlimb ischemic diabetic animals and is useful for prevention and/or treatment of peripheral artery disease in diabetic subjects. Copyright © 2012 M. Khazaei et al.
Other Related Docs
31. Oestrogen Promotes Coronary Angiogenesis Even Under Normoxic Conditions, Basic and Clinical Pharmacology and Toxicology (2008)
34. Imbalance of Angiogenesis in Diabetic Complications: The Mechanisms, International Journal of Preventive Medicine (2012)
35. The Effect of Captopril on Impaired Wound Healing in Experimental Diabetes, International Journal of Endocrinology (2012)
37. Coronary Angiogenesis During Experimental Hypertension: Is It Reversible?, Journal of Research in Medical Sciences (2011)
46. A Review on Angiogenesis and Its Assays, Iranian Journal of Basic Medical Sciences (2012)